WASHINGTON – The Patient-Centered Outcomes Research Institute Board of Governors has approved a three-year, $2.5 million demonstration project called the O2VERLAP Study, the American Sleep Apnea Association (ASAA) has announced.
MELBOURNE, Australia – CPAP therapy may not improve glycemic control for people with Type 2 diabetes and obstructive sleep apnea after all, according to a new study in the American Journal of Respiratory and Critical Care Medicine.
BALA CYNWYD, Pa. – Sleep Specialists’ Zzoma Positional Device was used in a study researching cost effectiveness of positional therapy to help treat obstructive sleep apnea (OSA), the medical device company announced yesterday.
WASHINGTON – Medicare does not reimburse for home oxygen used specifically to treat obstructive sleep apnea (OSA) because it is not the primary treatment for that disease, even if beneficiaries cannot tolerate PAP devices, CGS Associates said in a recent FAQ sent to providers.
LOS ANGELES – Obstructive sleep apnea (OSA) disrupts body functions controlling blood pressure, heart rate and sweating, more so in women than in men, according to a new study from the University of California, Los Angeles, School of Nursing.
DARIEN, Ill. – Researchers have found that continuous positive airway pressure (CPAP) therapy reduces the mortality rate of those with both chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), referred to as overlap syndrome.
WASHINGTON – A moderate case of obstructive sleep apnea (OSA) can significantly increase a person’s risk for sudden cardiac death (SCD), according to a large study published in the Journal of the American College of Cardiology.